Determination of Immunophenotypic Changes by CyTOF, Epigenetics and Component Resolved Diagnostics During Successful Desensitization in Multi-food Oral Immunotherapy

Sandra Andorf, M. Manohar, R. Chinthrajah, Sheena Gupta, H. Maecker, S. Galli, K. Nadeau
{"title":"Determination of Immunophenotypic Changes by CyTOF, Epigenetics and Component Resolved Diagnostics During Successful Desensitization in Multi-food Oral Immunotherapy","authors":"Sandra Andorf, M. Manohar, R. Chinthrajah, Sheena Gupta, H. Maecker, S. Galli, K. Nadeau","doi":"10.1145/3233547.3233644","DOIUrl":null,"url":null,"abstract":"Participants (n=44, age 4-15 yrs) with double-blind, placebo-controlled food challenge proven food allergy to multiple foods, were administered omalizumab (anti-IgE, n=40) or placebo (n=4) for 16 weeks with oral immunotherapy (OIT) for 2-5 foods, starting 8 weeks after the beginning of omalizumab or placebo (clinical outcomes of this trial in \\citeANDORF2018 ). To better understand the immunophenotypical changes leading to successful desensitization, we interrogated changes in immune cell subtypes in PBMCs before and after successful OIT using mass cytometry (CyTOF) on unstimulated as well as PMA/Ionomycin stimulated samples. The first step in this analysis was an unsupervised clustering across the markers within the CyTOF panel used for cell type identification (lineage markers) of a pooled dataset of all cells of the samples of the two time points. This was done through FlowSOM \\citeVanGassen2015, using self-organizing maps followed by hierarchical consensus meta-clustering. The immune cell subtype of each cluster was determined based on the expression level of the lineage markers of the cells within that cluster. The median level of various functional markers within each cluster were individually determined for each sample. Subsequently we tested whether the median level for each functional marker in each cell type (cluster) was significantly different between baseline and post-OIT. Further mechanistic experiments included epigenetics (pyrosequencing of bisulfite treated genomic DNA purified from participant's PBMCs) and component resolved diagnostics (ThermoFisher). Our preliminary results indicated a significant decrease (FDR-adjusted P < 0.01) of CD28 and GPR15 levels in effector memory CD4+ T cells after successful OIT compared to baseline. A significant increase (FDR-adjusted P < 0.01) in IL-10 was detected in the Treg and gamma-delta T cell populations. Epigenetic data demonstrated hypermethylation of the -48 CpG site in the IL-4 promoter region post-OIT (FDR-adjusted P < 0.01). The IgG4/IgE ratio of antibodies to most of the whole foods in the participant's OIT and to the corresponding storage proteins showed a significant increase (FDR-adjusted P < 0.01) between baseline and post-OIT. Our data thus imply that T cell anergy induced through OIT might contribute to successful desensitization.","PeriodicalId":131906,"journal":{"name":"Proceedings of the 2018 ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 2018 ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1145/3233547.3233644","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Participants (n=44, age 4-15 yrs) with double-blind, placebo-controlled food challenge proven food allergy to multiple foods, were administered omalizumab (anti-IgE, n=40) or placebo (n=4) for 16 weeks with oral immunotherapy (OIT) for 2-5 foods, starting 8 weeks after the beginning of omalizumab or placebo (clinical outcomes of this trial in \citeANDORF2018 ). To better understand the immunophenotypical changes leading to successful desensitization, we interrogated changes in immune cell subtypes in PBMCs before and after successful OIT using mass cytometry (CyTOF) on unstimulated as well as PMA/Ionomycin stimulated samples. The first step in this analysis was an unsupervised clustering across the markers within the CyTOF panel used for cell type identification (lineage markers) of a pooled dataset of all cells of the samples of the two time points. This was done through FlowSOM \citeVanGassen2015, using self-organizing maps followed by hierarchical consensus meta-clustering. The immune cell subtype of each cluster was determined based on the expression level of the lineage markers of the cells within that cluster. The median level of various functional markers within each cluster were individually determined for each sample. Subsequently we tested whether the median level for each functional marker in each cell type (cluster) was significantly different between baseline and post-OIT. Further mechanistic experiments included epigenetics (pyrosequencing of bisulfite treated genomic DNA purified from participant's PBMCs) and component resolved diagnostics (ThermoFisher). Our preliminary results indicated a significant decrease (FDR-adjusted P < 0.01) of CD28 and GPR15 levels in effector memory CD4+ T cells after successful OIT compared to baseline. A significant increase (FDR-adjusted P < 0.01) in IL-10 was detected in the Treg and gamma-delta T cell populations. Epigenetic data demonstrated hypermethylation of the -48 CpG site in the IL-4 promoter region post-OIT (FDR-adjusted P < 0.01). The IgG4/IgE ratio of antibodies to most of the whole foods in the participant's OIT and to the corresponding storage proteins showed a significant increase (FDR-adjusted P < 0.01) between baseline and post-OIT. Our data thus imply that T cell anergy induced through OIT might contribute to successful desensitization.
多种食物口服免疫治疗成功脱敏过程中免疫表型变化的细胞动力学、表观遗传学和成分分辨诊断测定
被证实对多种食物过敏的双盲、安慰剂对照食物刺激的参与者(n=44,年龄4-15岁),在开始服用奥玛珠单抗或安慰剂8周后,给予奥玛珠单抗(抗ige, n=40)或安慰剂(n=4) 16周,并给予口服免疫治疗(OIT) 2-5种食物(该试验的临床结果在\citeANDORF2018中)。为了更好地了解导致成功脱敏的免疫表型变化,我们使用细胞计数法(CyTOF)对未刺激和PMA/离子霉素刺激的样品进行了成功脱敏前后pbmc中免疫细胞亚型的变化。该分析的第一步是在CyTOF面板内的标记之间进行无监督聚类,该面板用于两个时间点样本的所有细胞的池数据集的细胞类型鉴定(谱系标记)。这是通过FlowSOM \citeVanGassen2015完成的,使用自组织地图,然后是分层共识元聚类。每个簇的免疫细胞亚型是根据该簇内细胞的谱系标记的表达水平确定的。在每个样本中,每个聚类中各种功能标记物的中位数水平被单独确定。随后,我们测试了每种细胞类型(集群)中每种功能标记物的中位数水平在基线和oit后是否有显著差异。进一步的机制实验包括表观遗传学(从参与者的PBMCs中纯化亚硫酸氢盐处理的基因组DNA的焦磷酸测序)和组分分解诊断(ThermoFisher)。我们的初步结果表明,与基线相比,成功OIT后效应记忆CD4+ T细胞中CD28和GPR15水平显著降低(经fdr校正P < 0.01)。IL-10在Treg和γ - δ T细胞群中显著升高(经fdr校正P < 0.01)。表观遗传学数据显示,oit后IL-4启动子区域-48 CpG位点发生了高甲基化(经fdr校正P < 0.01)。参与者的OIT中大多数天然食物的抗体的IgG4/IgE比率和相应的储存蛋白在基线和OIT后显示显著增加(经fdr调整的P < 0.01)。因此,我们的数据表明,通过OIT诱导的T细胞能量可能有助于成功脱敏。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信